RhoA activity assay
RhoA activity was measured using a RhoA activation assay kit (cytoskeleton, Denver, OH). Briefly, freshly prepared cell lysates of 800 μg total protein were incubated with 50 μg rhotekin-RBD beads at 4℃ on a rotator for 1h. After centrifugation, supernatant removal and carefully washing, the bead pellet was suspended in 2× Laemli buffer and boiled for 2 min. Then, the prepared samples were subjected for Western blotting using the anti-RhoA antibody included in the kit. Total RhoA expressions were also blotted as reference.
Protein array assay
To find out DLC3 downstream signaling, protein array assay was performed using Human Phospho-kinase array kit (R&D Systems, Minneapolis, MN) and following the manufacturer's protocol.
qRT-PCR
Trizol kit (Life science, Carlsbad, CA) for cells and tissues total RNA extraction and a reverse transcriptase (Roche, Penzberg, Germany) were used according to the protocols as recommended. qRT-PCR was performed using SYBR Green I Master kit (Roche) on a LightCycler 480 system. Primer sequences involved in present study are listed in online supplementary Table 1 .
Dual-luciferase reporter assay
According to the documented functional binding site for AP-1 in the MACC1 promoter [2], mutated MACC1 reporter fragments was generated (see online supplementary Table 2 ). To detect the influence of DLC3 on the MACC1 transcription, MACC1 and its corresponding mutated reporter fragments were cloned into the luciferase pGL3 vector. Luciferase activities of each groups was detected using DualLuciferase Reporter Assay System (Promega, Madison, WI, US) according to the manufacturer's instructions.
ROS detection and cell apoptosis assays
ROS was measured by fluorescent DCFH-DA dye (Jiancheng, Nanjing, China) and observed under fluorescent microscope after 6 hours glucose deprivation. Cell apoptosis was analyzed by staining Annexin V-FITC and Propidium Iodide after 12 hours glucose deprivation, and detected by flow cytometry analysis using the FACSCanto II system (BD Biosciences, San José, CA).
Cell viability, proliferation and colony formation assays
Cells viability was measured by methyl-thiazolyl-tetrazolium (MTT) assay as previously described [3] . Cell proliferation ability was reflected by EdU incorporation assay using the EdU Assay Kits (Life Technologies, Carlsbad, CA, USA) according to the manufacturer's instruction and observed under fluorescent microscope. For colony formation, trypsinized cells were suspended in 2 mL of complete medium (Sigma, St. and incubated with RPMI 1640 glucose free medium, while the lower chamber was supplemented with RPMI 1640 high glucose medium (2 g/L) as attractant. Cells were cultured for 48 hours before crystal violets staining.
Glucose uptake and pH evaluation
Cells were seeded on 6-well plates (5×10 5 /well) and cultured in 2 ml complete medium.
The 24-hour conditioned medium and the original medium (baseline control) were collected. Glucose uptake was determined using a glucose assay kit by conventional enzymatic methods (Randox, Antrim, UK). Total protein of cells was detected by conventional BCA method (Beyotime, Haimen, China). The pH value was detected by a pH meter. Tables   Supplementary Figure S1 DLC3 is associated with perfusion status in tumor microenvironment, and DLC3 low expression indicates poor cancer prognosis. (A) Quantified of the RhoA activity changes upon glucose deprivation by three independent repeats. (B) Using TCGA GC tissue data, the mRNA expressions of DLC family members in correlation with CD31, and three representative GEF members (TRIO, ARHGEF1 and MCF2L) were analyzed. Angiogenic factor VEGFA in correlation with DLC3 was also analyzed. (C and D) Using online Kaplan-Meier plotter for bioinformatic analysis, DLC3 downregulation was associated with poor survival in (C) breast cancer (GSE42568) and (D) lung cancer (CaArray) respectively. 
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